The emerging burden of heart failure in adults with congenital heart disease
Christopher J. Rush, John G.F. Cleland, Gruschen Veldtman
International Journal of Cardiology Congenital Heart Disease · 2021
doi:10.1016/j.ijcchd.2021.100171 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Ntiloudi et al. confirm the high burden of failure-related morbidity and mortality in adults with CHD. However, the pathways leading to heart failure in ACHD are heterogeneous and often poorly understood. Most importantly, there is a need for more randomized trials. Trials investigating effects on symptoms and surrogate measures of disease need not be large. However, much larger trials are required to investigate the effects of treatment on disease progression and prognosis, requiring collaborations at national and international levels, as is already the case for other forms of heart failure.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.